Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
BT8009 consists of a Nectin-4 binding bicyclic peptide in conjugation with the antimitotic toxin MMAE, which may deliver the toxin to Nectin-4-expressing tumor cells and results in tumor growth inhibition (Annals of Oncology (2020) 31 (suppl_4): S500-S501).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BT8009 + Nivolumab||BT8009 Nivolumab||0||1|